Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A newer revision, v3.5.0, was added and the older revision, v3.4.3, was removed.
    Difference
    0.1%
    Check dated 2026-03-18T19:46:47.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2 reference.
    Difference
    0.1%
    Check dated 2026-03-11T18:18:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-status notice (Revision: v3.4.1). These are minor page-level updates that do not affect study data or user actions.
    Difference
    0.4%
    Check dated 2026-02-11T04:43:34.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added a government funding notice banner and updated the page version to v3.4.1 (removing v3.4.0). The changes appear cosmetic and do not modify the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-04T05:32:03.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Non-substantive UI and wording updates include adding a glossary toggle and minor capitalization changes to QC-related metadata and the revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:57:58.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 is now displayed on the page. This is a minor metadata update and does not modify the study details, eligibility criteria, or user actions.
    Difference
    0.1%
    Check dated 2026-01-14T02:39:41.000Z thumbnail image

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.